HBLYX | JIASX | HBLYX / JIASX | |
Total Expense Ratio | 0.67 | 0.58 | 116% |
Annual Report Gross Expense Ratio | 0.67 | 0.70 | 96% |
Fund Existence | 19 years | 11 years | - |
Gain YTD | 9.048 | 9.743 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 1000000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.8B | 112M | 10,536% |
Annual Yield % from dividends | 3.44 | 5.68 | 60% |
Returns for 1 year | 2.51 | 8.66 | 29% |
Returns for 3 years | 25.18 | 38.82 | 65% |
Returns for 5 years | 17.35 | 24.72 | 70% |
Returns for 10 years | 48.84 | 52.87 | 92% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTGRX | 29.69 | 0.13 | +0.44% |
Fidelity Advisor Mega Cap Stock M | |||
ETAHX | 41.71 | 0.05 | +0.12% |
Eventide Healthcare & Life Sciences A | |||
WWMCX | 11.91 | 0.01 | +0.08% |
Westwood Quality Midcap Institutional | |||
IJPTX | 12.35 | N/A | N/A |
VY® JPMorgan Emerging Markets Equity S2 | |||
SUIIX | 62.95 | -0.14 | -0.22% |
DWS CROCI International Inst |